The Business Research Company
The Business Research Company’s Cardiac Marker Testing Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, July 30, 2026 /EINPresswire.com/ -- The cardiac marker testing market has been experiencing notable growth recently, driven by advancements in diagnostic technologies and increasing awareness of cardiovascular health. This sector plays a critical role in detecting heart-related conditions and is set to expand further as healthcare systems worldwide emphasize early diagnosis and better patient management.
Expanding Market Size of the Cardiac Marker Testing Industry
The cardiac marker testing market has seen rapid growth, with its value projected to rise from $7.19 billion in 2025 to $7.93 billion in 2026, representing a compound annual growth rate (CAGR) of 10.3%. This increase over the past years has been largely due to factors such as the limited availability of high-sensitivity cardiac marker tests, dependence on centralized lab testing, the rising prevalence of cardiovascular diseases, greater awareness among healthcare professionals, and the continued use of traditional manual diagnostic methods.
Download a free sample of the cardiac marker testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19358&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Future Growth Outlook for Cardiac Marker Testing Market
Looking ahead, the market for cardiac marker testing is expected to maintain strong momentum, reaching $11.61 billion by 2030 at a CAGR of 10.0%. This anticipated surge is driven by innovations like automated and portable testing devices, increased use of point-of-care diagnostics, integration with digital health platforms, a growing elderly population with heightened cardiovascular risks, and improvements in reagent and kit sensitivity. Noteworthy trends include the widespread adoption of high-sensitivity cardiac biomarker tests, expansion of point-of-care testing sites, the use of automated analyzers combined with immunoassay systems, rising utilization of cardiac marker testing in preventive cardiology, and greater demand for portable diagnostic tools.
Understanding Cardiac Marker Testing and Its Purpose
Cardiac marker testing encompasses a variety of diagnostic assessments designed to detect specific substances in the blood that signal heart muscle damage or stress. These markers, often proteins or enzymes, enter the bloodstream when cardiac injury occurs. These tests are essential for diagnosing and managing conditions like myocardial infarction (heart attack), heart failure, and a range of other cardiovascular disorders, providing vital information about the patient’s heart health.
View the full cardiac marker testing market report:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-testing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Jul_PR
Primary Factors Fueling Growth in Cardiac Marker Testing Market
The increasing prevalence of cardiovascular diseases is one of the main factors driving the expansion of the cardiac marker testing market. Cardiovascular diseases, which include coronary artery disease, heart failure, and stroke, are often linked to lifestyle factors such as poor diet, lack of exercise, tobacco use, excessive alcohol consumption, and exposure to air pollution. Cardiac marker testing is a critical tool for accurately diagnosing these conditions, determining their severity, and monitoring treatment effectiveness by identifying biomarkers released during heart muscle injury. For example, data released in January 2024 by the American Heart Association indicated that the age-adjusted death rate from cardiovascular disease in the US rose to 233.3 per 100,000, marking a 4.0% increase from 224.4 per 100,000 recorded in 2023. This upward trend in cardiovascular disease incidence directly fuels demand for cardiac marker testing.
Regional Leadership in Cardiac Marker Testing Market
In 2025, North America held the largest share of the cardiac marker testing market. Meanwhile, the Asia-Pacific region is predicted to be the fastest-growing market during the forecast period. The market analysis covers multiple key regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a broad view of worldwide market dynamics.
New additions to our 2026 reports:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
